Directed differentiation protocols for successful human intestinal organoids derived from multiple induced pluripotent stem cell lines

@inproceedings{Kauffman2015DirectedDP,
  title={Directed differentiation protocols for successful human intestinal organoids derived from multiple induced pluripotent stem cell lines},
  author={Amanda L. Kauffman and J. Ekert and Alexandra V. Gyurdieva and M. Rycyzyn and P. Hornby},
  year={2015}
}
  • Amanda L. Kauffman, J. Ekert, +2 authors P. Hornby
  • Published 2015
  • Biology
  • Abstract Background: Relatively little has been reported comparing the ability of different induced pluripotent stem cells (iPSCs) and protocols to derive human intestinal organoids (HIO), although there is potential to 
    5 Citations

    Figures and Tables from this paper

    Generation of endoderm lineages from pluripotent stem cells.
    • 4
    Towards an autologous iPSC-derived patient-on-a-chip
    • 3
    • PDF
    Modeling of drug-mediated CYP3A4 induction by using human iPS cell-derived enterocyte-like cells.
    • 25
    • PDF

    References

    SHOWING 1-10 OF 37 REFERENCES
    A Gutsy Task: Generating Intestinal Tissue from Human Pluripotent Stem Cells
    • 37
    • PDF
    Generating human intestinal tissue from pluripotent stem cells in vitro
    • 239
    • Highly Influential
    Defining stem cell types: understanding the therapeutic potential of ESCs, ASCs, and iPS cells.
    • 63
    • PDF
    Technological Overview of iPS Induction from Human Adult Somatic Cells
    • 91
    • PDF
    Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
    • 12,011
    • PDF
    A nonviral minicircle vector for deriving human iPS cells
    • 654
    • PDF
    An in vivo model of human small intestine using pluripotent stem cells
    • 322
    • Highly Influential
    Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro
    • 1,054
    • Highly Influential
    • PDF
    A comparative study of induced pluripotent stem cells generated from frozen, stocked bone marrow‐ and adipose tissue‐derived mesenchymal stem cells
    • 23